Suppr超能文献

用99mTc标记的抗癌胚抗原单克隆抗体CL58对局部复发性直肠癌进行免疫闪烁显像。

Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58.

作者信息

Yao Yun-Feng, Yang Zhi, Li Zhen-Fu, Gu Jin

机构信息

Peking University School of Oncology, Beijing 100036, China.

出版信息

World J Gastroenterol. 2007 Mar 28;13(12):1841-6. doi: 10.3748/wjg.v13.i12.1841.

Abstract

AIM

To explore a specific diagnostic method for local recurrent rectal cancer.

METHODS

Immunoscintigraphy with (99m)Tc-labeled anti-CEA monoclonal antibody (MoAb) CL-58 was performed for patients suspected of having a postoperative local recurrent rectal cancer and the findings were compared with the results of conventional imaging and pathology.

RESULTS

A total of 36 patients with a suspected local recurrent rectal cancer underwent immunoscintigraphy with (99m)Tc-conjugated CL58. Local recurrence of rectal cancer was identified in 31 patients and established in 30 during operation, endoscopy and pathological examination. No local recurrence was found in 5 patients without specific accumulation of (99m)Tc during the follow-up. Immunoscintigraphy had a positive rate of 86.11%, a specificity of 83.33%, and a sensitivity of 100%.

CONCLUSION

Immunoscintigraphy has a highly specific and predictive value for detecting local recurrent rectal cancer, especially after abdominal perineal resection (APR).

摘要

目的

探索局部复发性直肠癌的特异性诊断方法。

方法

对疑似术后局部复发性直肠癌的患者进行用(99m)锝标记的抗癌胚抗原单克隆抗体(MoAb)CL-58的免疫闪烁显像,并将结果与传统影像学和病理学结果进行比较。

结果

共有36例疑似局部复发性直肠癌的患者接受了用(99m)锝结合的CL58进行的免疫闪烁显像。31例患者被诊断为直肠癌局部复发,30例在手术、内镜检查和病理检查中得以确诊。5例在随访期间未发现(99m)锝特异性聚集的患者未出现局部复发。免疫闪烁显像的阳性率为86.11%,特异性为83.33%,敏感性为100%。

结论

免疫闪烁显像对检测局部复发性直肠癌具有高度特异性和预测价值,尤其是在腹会阴联合切除术(APR)后。

相似文献

1
Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58.
World J Gastroenterol. 2007 Mar 28;13(12):1841-6. doi: 10.3748/wjg.v13.i12.1841.
4
Clinical value of immunoscintigraphy in the rectal carcinomas: immunoscintigraphy of rectal carcinomas.
Hepatogastroenterology. 2013 Sep;60(126):1355-9. doi: 10.5754/hge121035.
8
In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer.
Cancer. 1993 Jun 15;71(12 Suppl):4241-7. doi: 10.1002/1097-0142(19930615)71:12+<4241::aid-cncr2820711813>3.0.co;2-g.

引用本文的文献

1
Targeted Alpha Therapy (TAT) with Single-Domain Antibodies (Nanobodies).
Cancers (Basel). 2023 Jul 4;15(13):3493. doi: 10.3390/cancers15133493.
2
Radiolabelled polymeric IgA: from biodistribution to a new molecular imaging tool in colorectal cancer lung metastases.
Oncotarget. 2017 Jul 27;8(49):85185-85202. doi: 10.18632/oncotarget.19616. eCollection 2017 Oct 17.
3
Imaging and cancer: a review.
Mol Oncol. 2008 Aug;2(2):115-52. doi: 10.1016/j.molonc.2008.04.001. Epub 2008 May 10.

本文引用的文献

1
Time trends in the treatment and survival of recurrences from colorectal cancer.
Ann Oncol. 2005 May;16(5):756-61. doi: 10.1093/annonc/mdi151. Epub 2005 Mar 24.
2
Results of treatment of distal rectal carcinoma since the introduction of total mesorectal excision: a single unit experience, 1994-2003.
Int J Colorectal Dis. 2005 May;20(3):221-30. doi: 10.1007/s00384-004-0670-9. Epub 2004 Dec 16.
3
Surgical treatment of locally recurrent rectal cancer.
Eur J Surg Oncol. 2004 Oct;30(8):857-63. doi: 10.1016/j.ejso.2004.05.020.
4
Endorectal ultrasound in the follow-up of rectal cancer patients treated by local excision or radical surgery.
Dis Colon Rectum. 2004 Jun;47(6):818-24. doi: 10.1007/s10350-004-0514-2. Epub 2004 Apr 19.
6
The value of immunoscintigraphy in the detection of recurrent colorectal cancer.
Nucl Med Commun. 2001 Dec;22(12):1295-304. doi: 10.1097/00006231-200112000-00004.
9
Colorectal cancer recurrence in the liver: detection by PET.
Tokai J Exp Clin Med. 1998 Oct;23(4):167-71.
10
Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.
Arch Surg. 1998 Aug;133(8):894-9. doi: 10.1001/archsurg.133.8.894.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验